GHK-Cu Injection Protocol: Dosage, Frequency, and What to Actually Expect

The Peptide the Biohacking World Can't Stop Talking About

Scroll through any peptide forum right now and you'll find someone absolutely convinced that GHK-Cu changed their skin, their recovery, or their life. There are detailed injection logs, before-and-after photos, and people debating subcutaneous versus intramuscular like it's a theological argument. The hype is real. But so is the confusion.

GHK-Cu (copper peptide GHK) is one of the more legitimately interesting compounds in the longevity toolkit. Unlike a lot of what circulates on health Twitter, there's actual research behind it, decades of it. The problem is that most of the detailed "protocol" content floating around online is either dangerously vague, completely wrong, or written by someone who learned everything from a Reddit thread. You deserve better than that.

This guide covers the complete GHK-Cu injection protocol: what you're actually injecting, how to reconstitute it correctly, where and how often to inject, how cycling works, and whether injections actually outperform the topical creams that are easier to get. No hype, no hand-waving. Just the information you need to decide if this is right for you, and how to do it safely if it is.

What Is GHK-Cu, Really?

GHK-Cu is a naturally occurring copper-binding tripeptide (three amino acids: glycine, histidine, lysine) that your body actually makes. It was first isolated from human plasma in 1973 by chemist Loren Pickart, who noticed it had a remarkable ability to stimulate tissue repair. The "Cu" part is copper, which binds to the peptide and appears to be critical to its function.

Here's the interesting part: your GHK-Cu levels decline significantly with age. At age 20, plasma concentrations sit around 200 ng/mL. By age 60, they've dropped to roughly 80 ng/mL. That's not a coincidence, because GHK-Cu does a lot of housekeeping work your body depends on.

Think of GHK-Cu as a cellular maintenance signal. When tissue is damaged or inflamed, GHK-Cu gets released to coordinate repair, dampening inflammation, stimulating collagen and elastin production, and activating genes involved in tissue remodeling. It's less like a drug and more like a message your body already knows how to read. The question is whether you can supplement that signal meaningfully, and whether injecting it delivers more than rubbing it on.

How GHK-Cu Works: The Mechanism (Without the Textbook)

Ready for some science that won't put you to sleep? GHK-Cu operates primarily at the level of gene expression. A landmark 2010 study by Pickart and colleagues found that GHK-Cu modulates the activity of more than 4,000 human genes, roughly 31% of the genome's most responsive elements. That's a staggering scope for a three-amino-acid molecule.

The key pathways include:

• Collagen and ECM synthesis: GHK-Cu upregulates collagen I, III, and IV production, along with elastin and proteoglycans (the structural proteins that make skin firm and joints resilient).
• Anti-inflammatory signaling: It suppresses the expression of pro-inflammatory cytokines including TGF-beta and TNF-alpha, which drive much of the tissue damage in aging and chronic injury.
• Antioxidant activity: The copper-bound form neutralizes reactive oxygen species (free radicals that damage cells) more effectively than GHK alone.
• Stem cell activation: Several studies suggest GHK-Cu can activate tissue stem cells, promoting regeneration in skin, nerves, and other tissues.
• DNA repair: More recent research points to roles in repairing oxidative DNA damage, which is directly relevant to biological aging.

Here's the catch: most of this mechanistic work is in cell cultures or animal models. The human clinical evidence is strongest for wound healing and skin, thinner everywhere else. That doesn't mean the other effects aren't real, it just means the dose-response relationship in living humans hasn't been as thoroughly mapped out yet.

Injections vs. Topical: Does It Actually Matter How You Deliver It?

This is the question most protocol guides skip. The honest answer is: yes, it probably matters, depending on what you're trying to achieve.

Topical GHK-Cu has the most robust clinical evidence. Multiple human studies show that topical formulations at concentrations of 1-5% meaningfully improve skin density, reduce fine lines, and accelerate wound healing. The skin is a permeable membrane, especially with the right carrier molecules, and topical delivery gets the peptide to dermal fibroblasts (the cells that build skin structure) fairly efficiently.

Injectable GHK-Cu bypasses the skin barrier entirely, delivering the peptide directly into systemic circulation or subcutaneous tissue. The theoretical advantage is broader reach: instead of only the area you apply cream to, your bloodstream carries the peptide to muscles, connective tissue, organs, joints, and potentially the central nervous system. In animal studies, systemic GHK-Cu has shown effects on lung repair, nerve regeneration, and inflammation that topical application simply can't replicate.

The trade-off is that you actually have to inject it correctly. And GHK-Cu is highly bioactive, meaning the dose, frequency, and reconstitution method all affect how well it works and whether you experience side effects.

The GHK-Cu Injection Protocol: A Practical Guide

Step 1: Sourcing and What You Need

Injectable GHK-Cu comes as a lyophilized (freeze-dried) powder in a sterile vial, typically in amounts of 5 mg or 10 mg per vial. Because it's sold as a "research peptide" in many markets, quality control is a genuine concern. The most critical thing here: you want pharmaceutical-grade, third-party tested product, ideally from a compounding pharmacy with a valid prescription. This is not the place to cut corners. Contaminated or incorrectly dosed research peptides have sent people to the ER.

You'll also need:

• Bacteriostatic water (BW) for reconstitution, not regular sterile water
• Insulin syringes (29-31 gauge, 0.5 mL)
• Alcohol swabs
• A dedicated sharps container

Step 2: Reconstitution

This step is where most DIY protocols go wrong. The goal is to get a concentration that makes your target dose easy to measure with an insulin syringe.

A common working concentration is 1 mg/mL. For a 5 mg vial, you'd add 5 mL of bacteriostatic water. For a 10 mg vial, add 10 mL. This means every 10 units on an insulin syringe equals 0.1 mg of GHK-Cu.

How to do it without destroying the peptide:

• Clean the rubber stopper of both vials with an alcohol swab and let it dry fully.
• Draw the bacteriostatic water into your syringe.
• Insert the needle into the peptide vial at a 45-degree angle and let the water run slowly down the inside glass wall, don't squirt it directly onto the powder.
• Gently swirl (don't shake) until the powder is fully dissolved. The solution should be clear.
• Store reconstituted GHK-Cu refrigerated at 2-8°C. Most sources suggest it remains stable for 4-6 weeks after reconstitution.

Step 3: Dosage

This is where you need clinical guidance, because dosing protocols in the research literature vary considerably and there's no universally agreed-upon human dose. That said, commonly used ranges in supervised protocols are:

• Starting dose: 0.5-1 mg per injection
• Maintenance dose: 1-2 mg per injection
• Higher-end protocols: Up to 2-3 mg per injection, though this is less common and carries more side effect risk

If you're new to GHK-Cu, start at 0.5 mg and assess tolerance before escalating. The principle here is the same as with any bioactive compound: begin low, move slowly.

Step 4: Injection Sites and Technique

Subcutaneous injection (SubQ) is the standard route for GHK-Cu. This means injecting into the fat layer just under the skin, not into muscle. Common sites are:

• Abdomen: Two inches away from the navel, rotating sites to avoid lipodystrophy (localized fat loss from repeated injections in the same spot)
• Outer thigh: Middle third of the thigh, lateral surface
• Love handles / flank: Pinchable subcutaneous fat, easy to access

Technique matters. Pinch the skin, insert the needle at a 45-degree angle (or 90 degrees if you have sufficient subcutaneous fat), inject slowly, withdraw, and apply gentle pressure with a swab. Don't rub. Rotate your injection sites systematically, ideally keeping a simple log of where you injected last.

Step 5: Frequency and Cycling

Daily injections are used in most published protocols, though some practitioners prefer every-other-day dosing to give the receptor system a break. A common structure:

• 5 days on / 2 days off (mirrors a standard workweek, reduces receptor desensitization)
• Cycle length: 8-12 weeks on, followed by a 4-week break

Why cycle at all? GHK-Cu receptors, like most peptide receptors, can downregulate with continuous stimulation. A rest period allows receptor sensitivity to reset, which is thought to preserve the compound's effectiveness over time. This is informed reasoning based on receptor biology, not a GHK-Cu-specific human RCT, so treat it as good practice rather than established science.

What the Evidence Actually Shows for Injectable GHK-Cu

Let's be specific about what's documented versus what's extrapolated.

• Wound healing and tissue repair: This is the strongest evidence base. A 2015 review in Biomolecules catalogued robust effects across multiple tissue types, including skin, bone, and nerve tissue, with systemic administration in animals showing accelerated regeneration.
• Anti-inflammatory effects: A 2018 study found GHK-Cu significantly reduced expression of genes associated with inflammatory diseases, with particular relevance to chronic inflammatory conditions. Human data is still limited but mechanistically sound.
• Hair growth: Multiple controlled studies show GHK-Cu stimulates hair follicle size and increases hair growth rate, comparable in some trials to 5% minoxidil. This is one of the better-evidenced human effects.
• Lung tissue repair: Animal studies show GHK-Cu reduces emphysema-like changes and fibrosis in lung tissue. Promising, but still mostly preclinical.
• Cognitive and neurological effects: GHK-Cu has been shown in cell culture studies to promote nerve growth factor expression and protect neurons from oxidative damage. You are not a neuron in a petri dish, so temper your expectations here.

The Reality Check

The internet wants GHK-Cu to be a total-body regeneration peptide. The research is more specific than that.

Most of the impressive systemic effects, the gene expression modulation, the nerve regeneration, the organ-level tissue repair, come from animal models using doses that are difficult to directly translate to humans. We don't have large, well-controlled human trials on injectable GHK-Cu for anti-aging or longevity endpoints. What we have is a mechanistically compelling compound with excellent safety data in topical applications, strong theoretical reasons to expect systemic benefits, and a growing body of practitioner experience that's encouraging but still largely anecdotal.

That's not a reason to dismiss it. It's a reason to approach it with eyes open, under clinical supervision, and with realistic expectations. You're not going to inject GHK-Cu for six weeks and reverse five years of aging. You might experience meaningfully faster recovery, improved skin quality, reduced joint inflammation, and better wound healing. Those are real outcomes worth pursuing. Just don't expect the biology to work like a movie montage.

Who Is GHK-Cu Injection Protocol Actually Right For?

Be honest with yourself about where you fit here.

You're likely a good candidate if you're:

• Over 40, when endogenous GHK-Cu levels have meaningfully declined
• Dealing with a specific recovery goal: a chronic soft-tissue injury, post-surgical healing, or joint inflammation that hasn't responded well to other approaches
• Already doing the fundamentals (sleep, training, nutrition) and looking for adjunct support
• Comfortable with injection protocols (or willing to learn proper technique)
• Working with a clinician who can monitor your response and adjust the protocol

You're probably not the right candidate if you're looking for a shortcut to results you haven't earned through lifestyle basics, or if you have copper metabolism disorders (Wilson's disease, Menkes syndrome), as GHK-Cu involves active copper transport and could theoretically exacerbate those conditions.

Risks and Side Effects: What to Know

GHK-Cu has an excellent safety profile relative to most peptides. That said, injection carries inherent risks that topical application doesn't.

• Injection site reactions: Redness, mild bruising, or swelling at the injection site are common, especially when starting out. Rotating sites helps.
• Copper excess: GHK-Cu delivers bioavailable copper. At standard doses this is unlikely to cause systemic copper overload, but people with impaired copper metabolism should avoid it without careful medical oversight.
• Contamination risk: Using non-pharmaceutical-grade peptides carries real infection risk. This is the single biggest safety issue in DIY peptide use.
• Nausea: Occasionally reported at higher doses, particularly early in a protocol. Usually resolves with dose reduction.
• Blood pressure: GHK-Cu may have mild vasodilatory effects. If you're on antihypertensive medication, flag this with your prescriber.

Clinical supervision addresses the majority of these risks. This isn't a compound to source, dose, and inject based on forum advice alone.

How to Get Started With GHK-Cu at Healthspan

Here's where the practical part comes in. The biggest problem with GHK-Cu protocols isn't the science, it's access to a clinician who actually understands the compound and can supervise a proper protocol. Most primary care doctors have never heard of GHK-Cu. Most peptide suppliers online are operating in a gray area with no medical oversight at all.

Healthspan's Longevity Optimization program is designed for exactly this situation. It starts with a comprehensive consultation and lab panel to establish your baseline, because GHK-Cu doesn't exist in a vacuum. Your inflammatory markers, your current copper status, your tissue repair goals, all of that context shapes whether this peptide belongs in your protocol and at what dose.

If you want a broader picture of where you're starting from before diving into a peptide protocol, the Longevity Pro Panel provides deep baseline biomarker data including inflammatory markers, metabolic function, and organ health that helps your clinician design a protocol that actually maps to your biology, not a generic template from a forum post.

The protocol includes physician-supervised dosing guidance, ongoing monitoring to track how your body is responding, and adjustments when needed. The goal isn't to hand you a vial and wish you luck. It's to build a protocol around your specific physiology and goals, with a clinician in your corner who can course-correct when the data warrants it.

If you're ready to take GHK-Cu seriously rather than just experiment with it, start with a Healthspan consultation and let the labs tell the real story.

Frequently Asked Questions About GHK-Cu Injection Protocol

What is the typical GHK-Cu injection dose for beginners?

Most supervised protocols start between 0.5 mg and 1 mg per injection for new users. Starting at 0.5 mg lets you assess tolerance before moving up. Experienced users typically work in the 1-2 mg range, with some protocols going to 2-3 mg. Always begin at the lower end and increase gradually, ideally with clinical oversight rather than based on forum recommendations.

How do you reconstitute GHK-Cu for injection?

Add bacteriostatic water to the lyophilized (freeze-dried) peptide vial to reach your target concentration. A common working concentration is 1 mg/mL, so a 5 mg vial would get 5 mL of bacteriostatic water. Let the water run slowly down the glass wall of the vial, then gently swirl until dissolved. Store reconstituted GHK-Cu refrigerated at 2-8°C and use within 4-6 weeks.

Is injectable GHK-Cu better than topical?

For skin-specific goals, high-quality topical GHK-Cu at 1-5% concentration has strong clinical evidence and is very effective. For systemic goals like tissue repair, joint health, or anti-inflammatory effects throughout the body, injections deliver the peptide into systemic circulation, which topical application cannot. So the answer depends on what you're trying to achieve. Many practitioners use both simultaneously.

How often should you inject GHK-Cu?

A common frequency is daily or 5 days on, 2 days off. Most supervised protocols recommend cycling: 8-12 weeks of active use followed by a 4-week break. This rest period is thought to prevent receptor desensitization and preserve the compound's effectiveness over repeated cycles. Daily continuous use without breaks is not typically recommended in clinical practice.

Where do you inject GHK-Cu?

GHK-Cu is typically administered via subcutaneous injection, meaning into the fat layer just under the skin rather than into muscle. Common sites include the abdomen (at least two inches from the navel), the outer thigh, and the flank. Rotating injection sites with each dose is important to prevent localized fat loss or skin changes at repeated injection points.

How long does it take to see results from GHK-Cu injections?

Results vary by goal. Skin quality improvements are often noticed within 4-8 weeks. Recovery and anti-inflammatory effects may be felt sooner, sometimes within the first two to three weeks, especially when there's an active healing goal. Systemic effects like tissue repair are harder to quantify without objective markers. Most protocols run 8-12 weeks before formally assessing outcomes.

What are the side effects of GHK-Cu injections?

GHK-Cu has a relatively favorable safety profile. The most common side effects are injection site reactions: mild redness, bruising, or swelling. Some people report nausea at higher doses early in a protocol. Because GHK-Cu carries bioavailable copper, people with copper metabolism disorders should avoid it. Using pharmaceutical-grade product from a compounding pharmacy under medical supervision significantly reduces contamination and dosing risks.